Jupiter Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$1.66M Sell
61,911
-78,568
-56% -$1.77M 0.03% 258
2020
Q1
$2.53M Buy
140,479
+26,336
+23% +$500K 0.05% 196
2019
Q4
$2.02M Buy
+114,143
New +$1.98M 0.03% 284
2019
Q2
Sell
-646,734
Closed -$10.4M 377
2019
Q1
$10.4M Sell
646,734
-916,260
-59% -$14.8M 0.1% 142
2018
Q4
$22.9M Buy
1,562,994
+369,267
+31% +$5.89M 0.2% 112
2018
Q3
$21.7M Buy
+1,193,727
New +$20.9M 0.15% 128
2016
Q2
Sell
-75,009
Closed -$710K 476
2016
Q1
$710K Buy
+75,009
New +$706K 0.01% 343

Other funds holding HALO

Jupiter Investment Management's HALO Position: Q2 2020 in Review

Jupiter Investment Management reduced its Halozyme (HALO) stake by 56% in Q2 2020, selling an estimated $1.77M and leaving 61,911 shares worth $1.66M. The position accounts for 0.03% of the portfolio, ranked #258.

Jupiter Investment Management first reported a position in HALO in Q1 2016 and has held it in 7 quarters since. The position peaked at $22.9M in Q4 2018. 264 funds tracked by Wall St. Rank hold HALO as of Q2 2020.

  • Jupiter Investment Management held 61,911 shares of Halozyme worth $1.66M as of Q2 2020.
  • Jupiter Investment Management sold 78,568 Halozyme shares in Q2 2020, an estimated $1.77M.
  • Halozyme made up 0.03% of Jupiter Investment Management's portfolio in Q2 2020, its #258 holding.
  • Jupiter Investment Management first reported a position in Halozyme in Q1 2016 and has held it in 7 quarters since.
  • Jupiter Investment Management's Halozyme position peaked at $22.9M in Q4 2018.
  • 264 funds tracked by Wall St. Rank held Halozyme as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.